System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Suleyman Arziman is an expert in Oncology at Muğla University (Turkey). Suleyman Arziman has authored 2 publications, the most recent in 2020. SLR score: 7 (community average: 125). How the SLR is computed.

LeadR Profile

Suleyman Arziman, PhD Muğla University Turkey
7 ScienceLeadR Reputation 7

Unlock

Register Login
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2023 - 2026
Source: PubMed

Ege University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 2

Citations

Citations: 3 1st author: 1 Last author: 0 Unique author: 0

Main journals

Ann Oncol 1
Med Oncol 1

Best Journals

Ann Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

Most recent indexed article

Source: Pubmed

Title Journal Year Citations
Salicylidene acylhydrazides attenuate survival of SH-SY5Y neuroblastoma cells through affecting mitotic regulator Speedy/RINGO and ERK/MAPK-PI3K/AKT signaling.
PMID 32691165 — neuroblastoma, cells, therapeutics, neoplasms, caspase 3		Med Oncol20203

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS